Menu
Back to User profile » Prof. Dr. Richard van Zyl-Smit
Papers published by Prof. Dr. Richard van Zyl-Smit:
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
van Zyl-Smit RN, Chapman KR, Kerstjens HAM, Gessner C, Sagara H, Tanase AM, Hosoe M, Pethe A, Lawrence D, Tillmann HC, D'Andrea P
Journal of Asthma and Allergy 2023, 16:123-134
Published Date: 20 January 2023
The Relationship Between Clinical Trial Participation and Inhaler Technique Errors in Asthma and COPD Patients
Perumal R, Leite M, van Zyl-Smit RN
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1217-1224
Published Date: 2 June 2020
Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis
Allwood BW, Maasdorp E, Kim GJ, Cooper CB, Goldin J, van Zyl-Smit RN, Bateman ED, Dawson R
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1039-1047
Published Date: 11 May 2020
A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa
Kokturk N, Abuharbid W, Albanna AS, Gunen H, Gurgun A, Khadadah M, Malvolti E, Soliman M, van Zyl-Smit R, Zidouni N, Alzaabi A
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2959-2970
Published Date: 20 December 2019
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study
Beeh KM, Kirsten AM, Tanase AM, Richard A, Cao W, Hederer B, Beier J, Kornmann O, van Zyl-Smit RN
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3923-3936
Published Date: 6 December 2018